skip to main content


U-M Rogel Cancer Center Urges Priority Access to the COVID-19 Vaccines for Cancer Patients and Survivors

130 organizations and cancer centers underscore the importance of prioritizing patients with active cancer and survivors of cancer for lifesaving COVID-19 vaccines.

Researchers Find Cellular Evidence Behind Lasting Immune Response in Some Cancer Survivors

Immunotherapy researchers have discovered how a subset of T cells known as memory T cells are generated in melanoma survivors with vitiligo and able to function for years after a tumor is gone.

Combination treatment for common glioma type shows promise in mice

These encouraging results, published in the Journal of Clinical Investigation, could be the first step toward developing a treatment for this type of brain cancer.